Article in Infection and immunity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
5 authors.
Samantha L AvinaSchool of Graduate Studies at the Health Science Campus, New Jersey Medical School, Rutgers University Newark, Newark, New Jersey, USA.ORCID 0000-0002-3918-7971
Siddhi PawarSchool of Graduate Studies at the Health Science Campus, New Jersey Medical School, Rutgers University Newark, Newark, New Jersey, USA.ORCID 0000-0002-9276-095X
Roshni N KadamSchool of Graduate Studies at the Health Science Campus, New Jersey Medical School, Rutgers University Newark, Newark, New Jersey, USA.
Amariliz RiveraCenter for Immunity and Inflammation, and Department of Pediatrics New Jersey Medical School, Rutgers University Newark, Newark, New Jersey, USA.ORCID 0000-0002-2173-5597
Chaoyang XuePublic Health Research Institute, and Department of Microbiology, Biochemistry, and Molecular Genetics, New Jersey Medical School, Rutgers University, Newark, New Jersey, USA.ORCID 0000-0001-8196-1468
Funding
Mechanisms of vaccine protection against AIDS-associated Cryptococcus infectionR01AI141368 · NIAID · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI Amariliz Rivera, Chaoyang Xue · 2019 to 2026
$5.4M
The role of inositol in Cryptococcus biology and pathogenesisR01AI123315 · NIAID · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI Chaoyang Xue · 2017 to 2026
$5.0M
Trained immunity and the regulation of anti-fungal defenseR01AI169769 · NIAID · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI Amariliz Rivera, Chaoyang Xue · 2022 to 2026
$3.1M
Role of phospholipids in antifungal drug resistance in Cryptococcus neoformansR01AI155647 · NIAID · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI Chaoyang Xue · 2022 to 2026
Currently, no fungal vaccine exists for clinical use, while fungal infections are responsible for over 1.5 million deaths every year. Our previous studies identified a
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Mannoprotein Cig1 contributes to the immunogenicity of a heat-killed F-box protein Fbp1 · full record | OpenQuestion